List of Excipients in API candesartan cilexetil and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing candesartan cilexetil and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | ATACAND HCT | candesartan cilexetil and hydrochlorothiazide | 54868-4729 | CARBOXYMETHYLCELLULOSE CALCIUM | |
| Physicians Total Care Inc | ATACAND HCT | candesartan cilexetil and hydrochlorothiazide | 54868-4729 | FERRIC OXIDE RED | |
| Physicians Total Care Inc | ATACAND HCT | candesartan cilexetil and hydrochlorothiazide | 54868-4729 | FERRIC OXIDE YELLOW | |
| Physicians Total Care Inc | ATACAND HCT | candesartan cilexetil and hydrochlorothiazide | 54868-4729 | HYDROXYPROPYL CELLULOSE | |
| Physicians Total Care Inc | ATACAND HCT | candesartan cilexetil and hydrochlorothiazide | 54868-4729 | LACTOSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing candesartan cilexetil and hydrochlorothiazide
Detailed excipient profiles for candesartan cilexetil and hydrochlorothiazide
Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
candesartan cilexetil and hydrochlorothiazide drug variants containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | candesartan cilexetil and hydrochlorothiazide | 68382-194 |
| Zydus Lifesciences Limited | candesartan cilexetil and hydrochlorothiazide | 70771-1325 |
| >Company | >Ingredient | >NDC |
candesartan cilexetil and hydrochlorothiazide drug variants not containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
candesartan cilexetil and hydrochlorothiazide drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
candesartan cilexetil and hydrochlorothiazide drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
candesartan cilexetil and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | candesartan cilexetil and hydrochlorothiazide | 43547-459 |
| >Company | >Ingredient | >NDC |
candesartan cilexetil and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: FERRIC OXIDE RED
candesartan cilexetil and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
candesartan cilexetil and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
candesartan cilexetil and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
candesartan cilexetil and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: GLYCERIN
candesartan cilexetil and hydrochlorothiazide drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | candesartan cilexetil and hydrochlorothiazide | 33342-131 |
| >Company | >Ingredient | >NDC |
candesartan cilexetil and hydrochlorothiazide drug variants not containing GLYCERIN
Excipient focus: GLYCERYL MONOSTEARATE
candesartan cilexetil and hydrochlorothiazide drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | candesartan cilexetil and hydrochlorothiazide | 0378-3001 |
| >Company | >Ingredient | >NDC |
candesartan cilexetil and hydrochlorothiazide drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYDROXYPROPYL CELLULOSE
candesartan cilexetil and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
candesartan cilexetil and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
candesartan cilexetil and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
candesartan cilexetil and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
candesartan cilexetil and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
candesartan cilexetil and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
candesartan cilexetil and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare LLC | candesartan cilexetil and hydrochlorothiazide | 43547-459 |
| >Company | >Ingredient | >NDC |
candesartan cilexetil and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
candesartan cilexetil and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 8000
candesartan cilexetil and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: STARCH, CORN
candesartan cilexetil and hydrochlorothiazide drug variants containing STARCH, CORN
candesartan cilexetil and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
